Real-time enrollment status for this recurrent diffuse large b-cell lymphoma, not otherwise specified clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 10:42 AM UTC
| NCT Number | NCT07365306 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified |
| Phase | PHASE2 |
| Target Enrollment | 43 participants |
| Active Locations | 3 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | August 28, 2026 (4 days ago) |
As of September 1, 2026: Clinical trial NCT07365306 is currently recruiting participants. This phase2 study for recurrent diffuse large b-cell lymphoma, not otherwise specified is actively seeking new participants at 3 locations across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07365306 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07365306 was last updated 4 days ago (August 28, 2026). HelloStudys verifies this status automatically.